Navigation Links
First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial
Date:1/23/2012

MILFORD, Mass., Jan. 23, 2012 /PRNewswire/ -- PLC Systems Inc. (OTC: PLCSF), a company focused on innovative medical device technologies, announced the successful enrollment of the first patient in the CIN-RG trial, the company's pivotal trial to study the efficacy of its RenalGuard Therapy® and RenalGuard System™ in the prevention of Contrast-Induced Nephropathy (CIN).  This is an important step in the process to secure regulatory approval by the U.S. Food and Drug Administration (FDA) for the distribution of RenalGuard® in the United States. 

The first patient was enrolled by Dr. Michael Kim, Director of the Coronary Care Unit at Mount Sinai Hospital in New York, New York.

"RenalGuard offers us the potential for a method to reduce the incidence of CIN while allowing me as an interventional cardiologist to focus on the catheterization without having to worry that the contrast may be damaging the patient's kidney," said Dr. Kim.

Dr. Roxana Mehran, Director of Interventional Cardiovascular Research at Mount Sinai and one of the three Principal Investigators in the CIN-RG Trial, said, "I am very excited to have this trial underway and overjoyed that Mount Sinai could enroll the first patient.  CIN remains a real problem for patients undergoing cardiac catheterizations. RenalGuard trials give us the opportunity to examine a tool that could significantly reduce the incidence of CIN in our at-risk patients."

Mark R. Tauscher, President and Chief Executive Officer of PLC, said, "We're very pleased to be able to move forward with our U.S. pivotal trial, starting with many of the hospitals that had participated in our earlier trial. The team at Mt. Sinai, particularly Dr. Mehran, has led the way in our understanding of CIN, and we are honored that they would choose to participate in the CIN-RG study.  Using lessons learned from the clinical trials of RenalGuard in Europe as well as other clinical devel
'/>"/>

SOURCE PLC Systems Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  In anticipation of the upcoming MEDevice ... available for the first time. Industry Overview: Medtech & ... offers a snapshot of San Diego,s ... from the latest employment statistics to current venture capital investment ... Diego such a vital part of the global ...
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, Inc., ... in noninvasive medical monitoring, today announced that the Food ... 3231 OEM/eHealth finger pulse oximeter for use in ... oximeter plugs into a telemedicine hub or kiosk through ... rate in pediatric to adult patients. The Model 3231 ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of ... health complications from the flu, pneumonia, shingles and ... have declared September to be Senior Vaccination ... age, it is important that adults ages 65 ... their vaccinations. CVS pharmacists and MinuteClinic nurse practitioners ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4
(Date:8/28/2014)... San Mateo, CA (PRWEB) August 28, 2014 ... announce that the MRI Technology program is re-accredited for ... Registry of Magnetic Resonance Imaging Technologists (ARMRIT). , ... re-accreditation. We are constantly improving our program to make ... There is a lot of interest in MRI field ...
(Date:8/28/2014)... Norton HealthDay Reporter THURSDAY, ... sending electrical currents through the scalp to a specific network ... a day. In a small study of healthy young ... certain networks involved in memory. That, in turn, boosted participants, ... after the brain stimulation. During TMS, an electromagnetic coil ...
(Date:8/28/2014)... fermentation," when yeast that should be busily converting grape ... leaving the remaining sugar to instead be consumed by ... of researchers including UC Davis yeast geneticist Linda Bisson ... Working through a prion -- an abnormally shaped ... bacteria in fermenting wine to switch yeast from sugar ...
(Date:8/28/2014)... 2014 Data from the American Hospital ... most hospitals utilize a basic electronic health record (EHR) ... is still a challenge. , This data is ... of Health Affairs , and is co-authored by Peter ... Center, as well as Chantal Worzala, director for policy ...
(Date:8/28/2014)... Journal of Medicine published research results on Aug. ... to safely reduce the viral load and clinical illness ... virus (RSV). , Le Bonheur Children,s Hospital ... Infectious Disease Specialist John DeVincenzo, MD, is lead author ... most common cause of lower respiratory tract infections in ...
Breaking Medicine News(10 mins):Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 2Health News:Electrical Pulses to Scalp May Boost Memory: Study 3Health News:Prions can trigger 'stuck' wine fermentations, researchers find 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 3Health News:DeVincenzo study breakthrough in RSV research 2
... Stop Wasting Precious Medicare Dollars on Trial Lawyers and,Focus ... Republican Whip,Roy Blunt (Mo.) today praised President Bush,s proposal ... "It is clear that without substantial reforms, Medicare ... tomorrow,s seniors. The legislation put,forth by the president is ...
... the following Webcast:, (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ), ... Quarter and ... Tuesday, February 26, 2008 @ 9:00 a.m. (MST], Where: ... Call link on ...
... Fla., Feb. 15 Ener1, Inc.,(OTC Bulletin Board: ... Herlihy, will deliver an investor presentation at the ... A.M. Pacific Standard,Time on Thursday, February 21st. The ... Ritz Carlton Laguna Niguel in Dana Point, California. ...
... /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that for the year ... million, or 62 cents per share, on revenues of $31.8,million ... cents per share, on,revenues of $27.6 million in the previous ... posted a net loss of $26.8 million, or 28,cents per ...
... conflicts had more health problems, study found , , FRIDAY, Feb. ... with others is more than a key to pleasant human ... , Researchers who studied a survey of almost 700 ... relatives, friends and neighbors were less likely to report health ...
... - Webcast on February 21st at 12:00 p.m. Pacific ... Inc. (Amex: SYI ) announced today that Noah ... will present at,the Roth 20th Annual OC Growth Stock ... time (3:00 p.m. Eastern time) at the Ritz,Carlton Hotel ...
Cached Medicine News:Health News:Blunt Praises President's Plan to Save Medicare 2Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2007 Earnings Conference Call Webcast 2Health News:Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference 2Health News:Westaim announces 2007 year-end results 2Health News:Westaim announces 2007 year-end results 3Health News:Westaim announces 2007 year-end results 4Health News:Westaim announces 2007 year-end results 5Health News:Westaim announces 2007 year-end results 6Health News:Westaim announces 2007 year-end results 7Health News:Westaim announces 2007 year-end results 8Health News:Westaim announces 2007 year-end results 9Health News:Westaim announces 2007 year-end results 10Health News:Westaim announces 2007 year-end results 11Health News:Westaim announces 2007 year-end results 12Health News:Unlike Fine Wine, Crabby People Don't Age Well 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 3Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3
Delicate membrane hook/pick with hook on side of instrument for engaging membranes. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare. Left....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 110 degrees. Most popular size or model....
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat...
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Medicine Products: